PT1313850E - Ácido nucleico e proteína correspondente denominados 85p1b3 úteis no tratamento e na detecção de cancro - Google Patents

Ácido nucleico e proteína correspondente denominados 85p1b3 úteis no tratamento e na detecção de cancro Download PDF

Info

Publication number
PT1313850E
PT1313850E PT01968204T PT01968204T PT1313850E PT 1313850 E PT1313850 E PT 1313850E PT 01968204 T PT01968204 T PT 01968204T PT 01968204 T PT01968204 T PT 01968204T PT 1313850 E PT1313850 E PT 1313850E
Authority
PT
Portugal
Prior art keywords
cancer
useful
detection
treatment
nucleic acid
Prior art date
Application number
PT01968204T
Other languages
English (en)
Inventor
Arthur B Raitano
Mary Faris
Rene S Hubert
Daniel Afar
Wangmao Ge
Pia Challita-Eid
Aya Jakobovits
Original Assignee
Agensys Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agensys Inc filed Critical Agensys Inc
Publication of PT1313850E publication Critical patent/PT1313850E/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
PT01968204T 2000-08-28 2001-08-28 Ácido nucleico e proteína correspondente denominados 85p1b3 úteis no tratamento e na detecção de cancro PT1313850E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US22843200P 2000-08-28 2000-08-28

Publications (1)

Publication Number Publication Date
PT1313850E true PT1313850E (pt) 2008-11-18

Family

ID=22857145

Family Applications (1)

Application Number Title Priority Date Filing Date
PT01968204T PT1313850E (pt) 2000-08-28 2001-08-28 Ácido nucleico e proteína correspondente denominados 85p1b3 úteis no tratamento e na detecção de cancro

Country Status (11)

Country Link
US (3) US7217799B2 (pt)
EP (2) EP2022797A3 (pt)
AT (1) ATE403716T1 (pt)
AU (3) AU2001288466B2 (pt)
CA (2) CA2420990C (pt)
CY (1) CY1109029T1 (pt)
DE (1) DE60135232D1 (pt)
DK (1) DK1313850T3 (pt)
ES (1) ES2311540T3 (pt)
PT (1) PT1313850E (pt)
WO (1) WO2002018578A2 (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001288466B2 (en) 2000-08-28 2007-03-29 Agensys, Inc. Nucleic acid and corresponding protein entitled 85P1B3 useful in treatment and detection of cancer
EP1799700A4 (en) * 2004-09-27 2009-02-11 Centocor Inc SRAGE MIMETIC BODIES, COMPOSITIONS, PROCESSES AND USES
US20110160288A1 (en) * 2008-08-28 2011-06-30 Oncotherapy Science, Inc. Oip5 as a target gene for cancer therapy and diagnosis
US8449512B2 (en) 2010-04-09 2013-05-28 Davinci Biomedical Research Products Inc. Stoma stabilitating device and method
CN114195861A (zh) * 2022-01-05 2022-03-18 许昌学院 亲和肽

Family Cites Families (59)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4179337A (en) 1973-07-20 1979-12-18 Davis Frank F Non-immunogenic polypeptides
US4235871A (en) 1978-02-24 1980-11-25 Papahadjopoulos Demetrios P Method of encapsulating biologically active materials in lipid vesicles
JPS6023084B2 (ja) 1979-07-11 1985-06-05 味の素株式会社 代用血液
US4640835A (en) 1981-10-30 1987-02-03 Nippon Chemiphar Company, Ltd. Plasminogen activator derivatives
US4722848A (en) 1982-12-08 1988-02-02 Health Research, Incorporated Method for immunizing animals with synthetically modified vaccinia virus
US4870009A (en) 1982-11-22 1989-09-26 The Salk Institute For Biological Studies Method of obtaining gene product through the generation of transgenic animals
US4501728A (en) 1983-01-06 1985-02-26 Technology Unlimited, Inc. Masking of liposomes from RES recognition
US4496689A (en) 1983-12-27 1985-01-29 Miles Laboratories, Inc. Covalently attached complex of alpha-1-proteinase inhibitor with a water soluble polymer
US4736866B1 (en) 1984-06-22 1988-04-12 Transgenic non-human mammals
US5019369A (en) 1984-10-22 1991-05-28 Vestar, Inc. Method of targeting tumors in humans
DE3675588D1 (de) 1985-06-19 1990-12-20 Ajinomoto Kk Haemoglobin, das an ein poly(alkenylenoxid) gebunden ist.
US4791192A (en) 1986-06-26 1988-12-13 Takeda Chemical Industries, Ltd. Chemically modified protein with polyethyleneglycol
US4837028A (en) 1986-12-24 1989-06-06 Liposome Technology, Inc. Liposomes with enhanced circulation time
GB8724885D0 (en) 1987-10-23 1987-11-25 Binns M M Fowlpox virus promotors
US5530101A (en) * 1988-12-28 1996-06-25 Protein Design Labs, Inc. Humanized immunoglobulins
US5225538A (en) 1989-02-23 1993-07-06 Genentech, Inc. Lymphocyte homing receptor/immunoglobulin fusion proteins
US5703055A (en) 1989-03-21 1997-12-30 Wisconsin Alumni Research Foundation Generation of antibodies through lipid mediated DNA delivery
DK0452457T3 (da) 1989-11-03 1998-03-02 Univ Vanderbilt Fremgangsmåde til in vivo fjernelse af funktionelle fremmede gener
US6673986B1 (en) 1990-01-12 2004-01-06 Abgenix, Inc. Generation of xenogeneic antibodies
SG48759A1 (en) 1990-01-12 2002-07-23 Abgenix Inc Generation of xenogenic antibodies
US6150584A (en) 1990-01-12 2000-11-21 Abgenix, Inc. Human antibodies derived from immunized xenomice
US5279833A (en) 1990-04-04 1994-01-18 Yale University Liposomal transfection of nucleic acids into animal cells
US5204253A (en) 1990-05-29 1993-04-20 E. I. Du Pont De Nemours And Company Method and apparatus for introducing biological substances into living cells
US5723286A (en) 1990-06-20 1998-03-03 Affymax Technologies N.V. Peptide library and screening systems
DE69132771T2 (de) 1990-06-27 2002-08-01 Princeton University Princeton Sonden für die detektion der p53 mutante
SE9002480D0 (sv) 1990-07-23 1990-07-23 Hans Lilja Assay of free and complexed prostate-specific antigen
US5733731A (en) 1991-10-16 1998-03-31 Affymax Technologies N.V. Peptide library and screening method
WO1993025673A1 (en) 1992-06-04 1993-12-23 The Regents Of The University Of California In vivo gene therapy with intron-free sequence of interest
EP1704868A1 (en) 1992-08-07 2006-09-27 Pharmexa Inc. HLA binding peptides and their uses
US5489525A (en) * 1992-10-08 1996-02-06 The United States Of America As Represented By The Department Of Health And Human Services Monoclonal antibodies to prostate cells
DE69435292D1 (de) 1993-03-05 2010-06-17 Epimmune Inc Verfahren zur herstellung von immunogenen hla-a2.1-bindenden peptiden
US5837501A (en) 1993-07-09 1998-11-17 Akzo Nobel N.V. Nucleic acid quantitation by co-amplification of target with multiple internal controls
US5804566A (en) 1993-08-26 1998-09-08 The Regents Of The University Of California Methods and devices for immunizing a host through administration of naked polynucleotides with encode allergenic peptides
US5679647A (en) 1993-08-26 1997-10-21 The Regents Of The University Of California Methods and devices for immunizing a host against tumor-associated antigens through administration of naked polynucleotides which encode tumor-associated antigenic peptides
AU698962B2 (en) 1993-09-14 1998-11-12 Epimmune, Inc. Alteration of immune response using pan DR-binding peptides
CH686982A5 (fr) 1993-12-16 1996-08-15 Maurice Stroun Méthode pour le diagnostic de cancers.
US5739118A (en) 1994-04-01 1998-04-14 Apollon, Inc. Compositions and methods for delivery of genetic material
WO1996002561A1 (en) 1994-07-20 1996-02-01 The General Hospital Corporation Interaction trap systems for detecting protein interactions
US5919652A (en) 1994-11-09 1999-07-06 The Regents Of The University Of California Nucleic acid molecules comprising the prostate specific antigen (PSA) promoter and uses thereof
US5736524A (en) 1994-11-14 1998-04-07 Merck & Co.,. Inc. Polynucleotide tuberculosis vaccine
US5962428A (en) 1995-03-30 1999-10-05 Apollon, Inc. Compositions and methods for delivery of genetic material
CA2217545A1 (en) 1995-04-11 1996-10-17 Marc Vidal Reverse two-hybrid systems
US5922687A (en) 1995-05-04 1999-07-13 Board Of Trustees Of The Leland Stanford Junior University Intracellular delivery of nucleic acids using pressure
CU22559A1 (es) 1996-01-17 1999-05-03 Ct Ingenieria Genetica Biotech Sistema de expresión de antígenos heterologos en e. coli como proteínas de fusión
JP2001504799A (ja) 1996-03-11 2001-04-10 エピミューン インコーポレイテッド Hla分子への結合アフィニティーが増加したペプチド
JP2000508923A (ja) 1996-04-26 2000-07-18 マサチューセッツ・インスティテュート・オブ・テクノロジー 3―ハイブリッド・スクリーニング・アッセイ
CA2262006A1 (en) 1996-07-26 1998-02-05 Sloan-Kettering Institute For Cancer Research Method and reagents for genetic immunization
US5925523A (en) 1996-08-23 1999-07-20 President & Fellows Of Harvard College Intraction trap assay, reagents and uses thereof
ATE371721T1 (de) 1996-10-15 2007-09-15 Univ California Tiermodelle für die menschliche prostatakrebsfortschreitung
US5846722A (en) 1996-10-16 1998-12-08 Terrapin Technologies, Inc. System to detect small molecule/peptide interaction
US5840501A (en) 1996-10-25 1998-11-24 Bayer Corporation Determination of cPSA
KR100942002B1 (ko) 1996-12-03 2010-02-12 암젠 프레몬트 인코포레이티드 복수의 vh 및 vk 부위를 함유하는 사람 면역글로불린 유전자좌를 갖는 형질전환된 포유류 및 이로부터 생성된 항체
US6261791B1 (en) * 1997-03-10 2001-07-17 The Regents Of The University Of California Method for diagnosing cancer using specific PSCA antibodies
EP0973896A2 (en) 1997-04-10 2000-01-26 Genetics Institute, Inc. SECRETED EXPRESSED SEQUENCE TAGS (sESTs)
CA2402563A1 (en) 1999-12-23 2001-07-26 Hyseq, Inc. Novel nucleic acids and polypeptides
CA2394841A1 (en) 2000-01-31 2001-08-02 Steven C. Barash Nucleic acids, proteins, and antibodies
JP2004508019A (ja) 2000-07-28 2004-03-18 コンピュジェン インコーポレイテッド トランスクリプトームの中に場所を占めるrna転写物及びスプライス変異体を検出するためのオリゴヌクレオチドライブラリー
GB0031021D0 (en) 2000-07-31 2001-01-31 Aventis Pharma Ltd Polynucleotides and polypeptides
AU2001288466B2 (en) 2000-08-28 2007-03-29 Agensys, Inc. Nucleic acid and corresponding protein entitled 85P1B3 useful in treatment and detection of cancer

Also Published As

Publication number Publication date
DK1313850T3 (da) 2008-12-01
US8173381B2 (en) 2012-05-08
EP2022797A2 (en) 2009-02-11
EP1313850A2 (en) 2003-05-28
WO2002018578A2 (en) 2002-03-07
CA2420990C (en) 2010-08-17
WO2002018578A3 (en) 2002-10-03
DE60135232D1 (de) 2008-09-18
US20070036762A1 (en) 2007-02-15
AU2007202977B2 (en) 2010-06-03
US20030170626A1 (en) 2003-09-11
EP1313850B1 (en) 2008-08-06
CA2705366A1 (en) 2002-03-07
CY1109029T1 (el) 2014-07-02
EP2022797A3 (en) 2011-11-09
US7501502B2 (en) 2009-03-10
US7217799B2 (en) 2007-05-15
AU2007202977A1 (en) 2007-07-19
AU2001288466B2 (en) 2007-03-29
AU8846601A (en) 2002-03-13
ATE403716T1 (de) 2008-08-15
AU2001288466B9 (en) 2002-03-13
ES2311540T3 (es) 2009-02-16
CA2420990A1 (en) 2002-03-07
US20090203016A1 (en) 2009-08-13

Similar Documents

Publication Publication Date Title
HK1110876A1 (en) Nucleic acid and corresponding protein named 158p1d7 useful in the treatment and detection of bladder and other cancers
WO2004016733A3 (en) Nucleic acid and corresponding protein entitled 251p5g2 useful in treatment and detection of cancer
WO2003022995A3 (en) Nucleic acid and corresponding protein entitled steap-1 useful in treatment and detection of cancer
DE60041333D1 (de) Hen prostatkrebs exprimiert wird, und deren verwendungen
WO2003040340A3 (en) Nucleic acid and corresponding protein entitled 161p2f10b useful in treatment and detection of cancer
BR9808509A (pt) Composições e métodos para o tratamento e diagnóstico do câncer de mama
EP1706423B8 (en) Therapeutic and diagnostic anti-hsp 70 antibodies
WO2003050255A3 (en) Nucleic acid and corresponding protein entitled 193p1e1b useful in treatment and detection of cancer
WO2002014361A3 (en) NUCLEIC ACIDS AND CORRESPONDING PROTEINS ENTITLED 83P2H3 AND CaTrF2E11 USEFUL IN TREATMENT AND DETECTION OF CANCER
EP2366711A3 (en) Nucleic acid and corresponding protein entitled 125P5C8 useful in treatment and detection of cancer
AU8846601A (en) Nucleic acid and corresponding protein entitled 85p1b3 useful in treatment and detection of cancer
WO2004072263A3 (en) Nucleic acid and corresponding protein named 158p1d7 useful in the treatment and detection of bladder and other cancers
AU2002303340A8 (en) Nucleic acid and corresponding protein entitled 184p1e2 useful in treatment and detection of cancer
WO2002014501A3 (en) Nucleic acids and corresponding proteins entitled phor1-a11 and phor1-f5d6 useful in treatment and detection of cancer
WO2003020954A3 (en) 205p1b5 in treatment and detection of cancer
WO2003080800A3 (en) Prevention and treatment of disease using angiogenesis-and/or tumor antigens
WO2002092842A3 (en) Nucleic acids and corresponsing proteins entitled 101p3a11 or phor-1 useful in treatment and detection of cancer
DK1967586T3 (da) 84P2A9: prostata- og testikelspecifikt protein med høj ekspression ved prostatacancer
WO2001079557A3 (en) Gtp-binding protein useful in treatment and detection of cancer
PT1434592E (pt) Ácido nucleico e correspondente proteína intitulada 121p2a3 úteis no tratamento e detecção de cancro
WO2001075001A3 (fr) Nouveau polypeptide, protéine kinase humaine dépendant de l'adénosine cyclique 9, et poynucléotide codant pour ce polypeptide
WO2001075022A3 (fr) Nouveau polypeptide, eucaryon acetyl transferase humaine 12, et polynucleotide codant pour ce polypeptide
WO2001075026A3 (fr) Nouveau polypeptide, eucaryote acetyl transferase humaine 10, et polynucleotide codant pour ce polypeptide
WO2001094540A3 (fr) Nouveau polypeptide, glycosyl hydrolase humaine 23, et polynucleotide codant ce polypeptide